Publications by authors named "J Zabaleta"

Introduction: B-cell acute lymphoblastic leukemia (B-ALL) in adults often presents a poor prognosis. ID1 and ID3 genes have been identified as predictors of poor response in Colombian adult B-ALL patients, contributing to cancer development. In various cancer models, these genes have been associated with immune regulatory populations within the tumor immune microenvironment (TIME).

View Article and Find Full Text PDF
Article Synopsis
  • A 16-year-old girl diagnosed with right-sided hemiparesis from a neonatal stroke has a missense mutation in her Protein S gene, linked to a hereditary deficiency seen in her father and grandfather.
  • The girl was closely monitored by her physician and underwent various blood tests starting at age 13, revealing low Protein S activity and prolonged clotting times.
  • After receiving her COVID-19 vaccinations in 2021 and 2022, her clotting parameters improved significantly, suggesting that the vaccine may reduce thrombosis risk in individuals with inherited thrombophilia.
View Article and Find Full Text PDF

Diversifying the biomedical research workforce is crucial for eliminating cancer health disparities. To address this need, Moffitt Cancer Center and Louisiana State University Health Sciences formed the Southeast Partnership for Improving Research and Training in Cancer Health Disparities (SPIRIT-CHD). A key component of SPIRIT-CHD is the Cancer Research Education Program (CREP), designed to train underrepresented undergraduate and medical students in biomedical science research.

View Article and Find Full Text PDF

The COVID-19 pandemic reminded us of the urgent need for new antivirals to control emerging infectious diseases and potential future pandemics. Immunotherapy has revolutionized oncology and could complement the use of antivirals, but its application to infectious diseases remains largely unexplored. Nucleoside analogs are a class of agents widely used as antiviral and anti-neoplastic drugs.

View Article and Find Full Text PDF

Background: Mediastinal lymph node staging is a key element in the diagnosis of lung cancer. The combination of computed tomography (CT) and positron emission tomography (PET) has improved staging but some circumstances are known to influence their negative predictive value. The objective of this study was to assess the impact on survival of avoiding invasive mediastinal staging in surgical lung cancer patients with negative mediastinum in CT and PET and intermediate risk of unexpected pN2.

View Article and Find Full Text PDF